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Introduction: Marked weakness of the quadriceps muscles is typically observed following injury, surgery or
pathology affecting the knee joint. This is partly due to ongoing neural inhibition that prevents the central nervous
system from fully activating the quadriceps, a process known as arthrogenic muscle inhibition (AMI). This study
aimed to further investigate the mechanisms underlying AMI by exploring the effects of experimental knee joint
effusion on quadriceps corticomotor and intracortical excitability.
Methods: Seventeen healthy volunteers participated in this study. Transcranial magnetic stimulation was used to
measure quadriceps motor evoked potential area, short-interval intracortical inhibition, intracortical facilitation and
cortical silent period duration before and after experimental knee joint effusion. Joint effusion was induced by the
intraarticular infusion of dextrose saline into the knee.
Results: There was a significant increase in quadriceps motor evoked potential area following joint infusion, both
at rest (P = 0.01) and during voluntary muscle contraction (P = 0.02). Cortical silent period duration was significantly
reduced following joint infusion (P = 0.02). There were no changes in short interval intracortical inhibition or
intracortical facilitation over time (all P > 0.05).
Conclusions: The results of this study provide no evidence for a supraspinal contribution to quadriceps AMI.
Paradoxically, but consistent with previous observations in patients with chronic knee joint pathology, quadriceps
corticomotor excitability increased after experimental knee joint effusion. The increase in quadriceps corticomotor
excitability may be at least partly mediated by a decrease in gamma-aminobutyric acid (GABA)-ergic inhibition
within the motor cortex.Introduction
Marked weakness and atrophy of the quadriceps muscle is
often observed after knee injury, knee surgery or in patients
with knee joint arthritis. This is partly caused by an ongoing
neural activation deficit of the quadriceps, a process known
as arthrogenic muscle inhibition (AMI) (for a review see
[1]). The effect of AMI on quadriceps strength is striking,
with knee extensor peak torque decreasing by 80 to 90%
one to three days after knee joint surgery [2,3]. Despite
diminishing over time [4], residual levels of AMI may* Correspondence: david.rice@aut.ac.nz
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unless otherwise stated.persist as long as 4 years after initial joint trauma [5]. Fur-
thermore, AMI appears to be ever present in arthritic joint
disease [6], accounting for a large amount of the quadriceps
muscle weakness observed in these individuals [7].
As well as being a direct cause of quadriceps muscle
weakness, AMI may prevent effective muscle strengthen-
ing [8,9], leading to long-term quadriceps muscle atrophy
and weakness that is difficult to reverse. Ongoing quadri-
ceps weakness is clinically important, as it is associated
with impaired dynamic knee-joint stability [10] and phys-
ical function [11,12]. Moreover, weaker quadriceps have
been associated with an increased rate of loading at the
knee joint [13] and recent longitudinal data has shown
that greater baseline quadriceps strength may protect
against incident knee pain [14], patellofemoral cartilage
loss [14] and tibiofemoral joint-space narrowing [15].is is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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lying AMI are only partially understood. AMI has been
linked to knee joint swelling, pain and structural damage
[1]. The relative contribution of these factors is unclear
but it is known that swelling alone provokes potent
quadriceps AMI. This has been repeatedly demonstrated
by the experimental infusion of fluid into healthy, unin-
jured joints. These studies have shown that intra-
articular swelling substantially reduces quadriceps peak
torque [16,17], electromyographic (EMG) activity [16,18]
and H-reflex amplitude [19,20], despite the absence of
structural damage, joint inflammation or pain. It has
been reported that as little as 10 ml of fluid may induce
inhibition [17] with infusions between 20 and 60 ml
capable of reducing maximum effort quadriceps peak
torque by 30 to 40% [17,21]. Aspirating or injecting a local
anaesthetic into the infused joint largely abolishes AMI
[17,20], while the prior injection of local anaesthetic pre-
vents AMI with subsequent joint infusion [17], confirming
the role of articular sensory receptors in this process.
Studies in animals [22,23] have shown that joint infu-
sion elevates intra-articular pressure, stimulating stretch
and pressure-sensitive mechanoreceptors and greatly in-
creasing group-II joint afferent discharge. Group-II joint
afferents are known to excite group-I non-reciprocal (Ib)
inhibitory interneurons in the spinal cord [24], which in
turn inhibit quadriceps α-motoneurons and prevent full
activation of the muscle [25]. Thus, AMI appears to be
at least partly mediated by increased spinal reflex inhib-
ition of the quadriceps α-motoneuron pool.
It is unclear whether supraspinal pathways also contrib-
ute to AMI. Two studies [26,27] have utilised transcranial
magnetic stimulation (TMS) to show that quadriceps
corticomotor excitability is altered in individuals with knee
joint pathology. However, these cross-sectional studies
were performed following long-term joint pathology, mak-
ing it difficult to elucidate the effects of joint injury from
other factors such as disuse, medication use and varying
rehabilitation programmes. Furthermore, the magnitude
of AMI, and hence its clinical impact, is typically greatest
in the acute stages after joint injury or surgery [2-4]. Thus,
the purpose of this study was to explore the acute effects
of experimental knee joint swelling on quadriceps corti-
comotor and intracortical excitability. Our hypotheses
were that experimental joint infusion would lead to 1) a
decrease in quadriceps corticomotor excitability and 2) a
reduction in intracortical excitability, reflected by an




Seventeen participants (eleven male and six female)
volunteered to take part in this study. Participants werescreened and excluded based on contraindications to
TMS, including epilepsy, head injury, metal implants, or
central nervous system-altering medications. Further
exclusion criteria were previous history of pathology in
both knee joints, a history of lower limb or spinal sur-
gery, or a history of neurological disease. In the event of
a previous knee injury, the contralateral (uninjured) knee
joint was used in testing. Participants were asked to
refrain from ingesting caffeine, alcohol or medication for
4 hours prior to testing. All participants provided writ-
ten informed consent for the experimental procedures.
Ethical approval for this study was granted by the Northern
X Regional Ethics Committee, Auckland, New Zealand in
accordance with the principles set out in the declaration
of Helsinki.
Participant positioning
Participants were positioned in an isokinetic dynamom-
eter (Biodex 3, Biodex Medical Systems, Shirley, NY,
USA) for the duration of the experimental procedures.
The lateral epicondyle of the femur was aligned with the
dynamometer’s axis of rotation and the knee fixed in 60°
of flexion. Straps were firmly secured over the distal
tibia, waist and chest to limit extraneous movement
during the testing procedures.
Experimental knee joint infusion
With the knee resting in slight flexion, a 23-g cannula was
inserted into the superomedial or, on two occasions, the
superolateral aspect of the joint. All injections were
performed without local anaesthesia, under strictly sterile
conditions. A pressure transducer (Medex Inc., Dublin,
OH, USA) and syringe were attached in parallel with the
cannula via a three-way tap and pressure-resistant tubing.
A dextrose saline solution (4% dextrose and 0.19% NaCl)
was injected into the joint space in increments of 15 ml or
less. Intra-articular pressure was monitored for each
participant and infusion stopped when intra-articular
pressure reached 50 mmHg. A standardised pressure of
50 mmHg was chosen as this has previously been shown
to lead to notable quadriceps AMI and is well-tolerated by
participants [16,18]. Importantly, we chose to standardise
the infusion to intra-articular pressure as a set volume of
infusion (for example, 60 ml) provides a relatively poor es-
timate of capsular tension due to large individual differ-
ences in both the size of the joint cavity and capsular
elastance. Both joint afferent discharge [23] and quadri-
ceps AMI [18] have a stronger correlation with intra-
articular pressure compared to intra-articular volume. The
pain sensation evoked by the joint infusion was measured
after the withdrawal of the cannula from the joint and just
prior to the post infusion measurements. Participants were
asked to verbally rate any pain they felt in their knee on a
scale from 0 (no pain) to 100 (worst pain imaginable).
Figure 1 Diagram illustrating the study protocol. Maximum effort
voluntary contractions (MVC) of the quadriceps were performed prior
to the first measurements of the dependent variables. After a 5-minute
rest period, transcranial magnetic stimulation was used to measure the
dependent variables at baseline 1 (B1), 10 minutes later at baseline 2
(B2) and then immediately after experimental knee joint infusion (P1).
At each measurement interval the dependent variables were measured
with the quadriceps at rest (resting condition) and then during a
quadriceps contraction at 10% of maximum voluntary contraction
(active condition).
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To collect quadriceps motor-evoked potentials (MEPs), bi-
polar Ag-AgCl disc electrodes (Norotrode 20, Myotronics
Inc., Kent, WA, USA) with an inter-electrode distance
of 2.2 cm were placed on the skin overlying the vastus
lateralis muscle belly in accordance with surface electro-
myography for the non-invasive assessment of muscles
(SENIAM) guidelines [28]. A ground electrode (Red Dot,
3 M, St Paul, MN, USA) was positioned slightly below
the midpoint of the bony surface of the tibia. Prior to
electrode placement the skin was shaved, abraded and
cleaned with alcohol to reduce signal impedance. All
EMG signals were amplified (x1,000), filtered (10 Hz to
1,000 Hz) (AMT-8, Bortec Biomedical, Alberta, Canada)
and sampled at 2,000 Hz (Micro 1401, Cambridge Elec-
tronic Design, Cambridge, UK) before being stored on a
computer for further analysis. Three 5-s maximum effort
voluntary contractions of the quadriceps were performed
prior to the first baseline measurements. The largest amp-
litude root mean square of the vastus lateralis EMG signal
within a 1-s window was taken as the MVC. This was used
to standardise the level of muscle activation (approxi-
mately 10% of MVC) during the TMS measures per-
formed during active muscle contraction.
Transcranial magnetic stimulation
To minimise the effect of strong voluntary contractions
on corticomotor excitability [29], a 5-minute rest period
was given between the performance of MVCs and the
beginning of TMS procedures. Stimuli were delivered
over the scalp using a BiStim 2002 and a double cone
coil (Magstim Company, Whitland, UK). The coil was
placed over the contralateral primary motor cortex so
that the induced current flow was in a posterior-anterior
direction. First, the optimum site for stimulation (hot
spot) was found by delivering a series of suprathreshold
stimuli as the coil was systematically moved over the
scalp until the largest quadriceps MEP was elicited. This
was typically found approximately 1 to 2 cm lateral and
anterior to the vertex. The hot spot was marked on the
scalp with a felt pen and all further testing completed
with the coil held directly over this position. The loca-
tion of the coil on the participant’s head was checked
repeatedly to ensure that the location and angle of
stimulation remained unchanged. Resting motor thresh-
old (RMT) was determined using a staircase method and
was defined as the lowest stimulation intensity (% of
maximum stimulator output) evoking a clearly discern-
able MEP in four of eight consecutive stimuli. The active
motor threshold (AMT) was determined in an identical
manner while maintaining a voluntary quadriceps
contraction at approximately 10% of MVC. To achieve
this level of activation, participants were given real-time
visual feedback of their EMG signal.Dependent variables
The following dependent variables were examined from
the quadriceps: 1) MEP area, 2) cortical silent period
(CSP) duration, 3) short interval intracortical inhibition
(SICI) and 4) intracortical facilitation (ICF). Single-pulse
TMS (test stimuli only) was used to elicit the quadriceps
MEPs and the CSP, while paired pulse TMS (condition-
ing and test stimuli) was used to measure SICI and ICF.
MEP area provides a measure of overall corticomotor
excitability, while the CSP duration, SICI and ICF pro-
vide information on the excitability of intracortical path-
ways (that is, within the motor cortex itself ). MEP area,
SICI and ICF were collected with the quadriceps muscle
quiescent (resting condition) and during a tonic volun-
tary muscle contraction at approximately 10% of MVC
(active condition). The CSP duration was collected dur-
ing the active condition only. For the resting condition,
the test stimuli were delivered with a stimulation inten-
sity of 120% RMT and the conditioning stimuli at 70%
and 90% of RMT for SICI and ICF, respectively. For the
active condition, the test stimuli were set to 120% AMT
and the conditioning stimuli set to 70% and 90% of
AMT for SICI and ICF, respectively. For both the resting
and active conditions, an interstimulus interval of 2 ms
was used for SICI and 15 ms for ICF.
Protocol
All TMS parameters were collected at baseline (B1) and
again after a 10-minute rest period (B2) (Figure 1). At all
measurement intervals, 8 single pulse and 16 paired
pulse stimuli (8 SICI, 8 ICF) were delivered first at rest
and then during quadriceps contraction. The order of
the stimuli was randomised and an interstimulus interval
of 6 s was used. Following joint infusion (P1), eight sin-
gle pulse stimuli were delivered at rest using the same
stimulus intensity as B1 and B2. If necessary, the test
stimulus intensity was then adjusted for the subsequent
measures of SICI and ICF to ensure that a test MEP of the
same size (±10%) as B1 test MEP was evoked [30,31]. This
process was repeated for the outcome measures in the
Table 1 Summary of dependent variables at each
measurement interval
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gle pulse stimuli to assess the CSP. The conditioning
stimulus intensity remained unchanged across all meas-
urement points.
Data processing and analysis
For the resting condition, the EMG signal was rectified
and the 50 ms preceding the stimulus artefact was visu-
ally checked for contamination by voluntary muscle ac-
tivity. Responses were removed from further analysis if
silence in the EMG signal was not maintained (<5% of
recordings discarded). As the recorded MEPs were typic-
ally polyphasic (Figure 2), the area of the averaged, recti-
fied MEP was calculated [32]. For both the resting and
active conditions, the MEP areas at the B2 and P1 meas-
urement points were normalised to MEP area at B1.
SICI and ICF were determined by expressing the aver-
aged MEP area of the conditioned response relative to
the averaged MEP area of the corresponding test (single
pulse) response at each measurement period [30]. The
CSP duration was calculated as the time from stimulus
onset to the first return of the EMG to the mean recti-
fied prestimulus EMG [33].
Statistical analysis
Normality of the dependent variable distributions was
checked using the Shapiro-Wilk test. The one-sample t-
test was used to assess whether normalised MEP area
was significantly different from B1 at the B2 or P1 time
points. One-sample repeated-measures analysis of vari-
ance (ANOVA) was utilised to analyse differences in
SICI and CSP duration over time. In the event that a sig-
nificant effect of time was found, planned contrasts were
used to assess whether the variables differed significantly
from B1 at the B2 or P1 time points. As ICF did not
conform to a normal distribution in either the resting or
active conditions, Friedman’s test was used to analyseFigure 2 Rectified motor evoked potential (MEP) recorded from
the quadriceps during active muscle contraction. Note the
stimulus artefact (initial large positive deflection) followed by the
larger polyphasic MEP and then the silent period in the ongoing
EMG following the MEP (cortical silent period).this variable over time. Repeated-measures ANOVA was
utilised to ensure that the RMS level of background
EMG in the 50 ms preceding the stimulus artefact did
not differ over time during the active condition. The
alpha level for all statistical tests was set to P <0.05.
Results
The mean (±1 SD) age, height and mass of the partici-
pants were 32 ± 10 years, 1.78 ± 0.09 metres and 76 ±
14 kg, respectively. Four participants had a history of
knee joint pathology in the contralateral (untested) limb.
Quadriceps MEPs were unable to be obtained in 3 out
of 17 participants during the resting condition (that is,
120% of RMT >100% of maximum stimulator output).
Dependent variables were collected from all 17 partici-
pants during the active condition. A summary of the
main findings is presented in Table 1.
Joint infusion
Upon insertion of the catheter into the knee joint,
intraarticular pressure was typically negative or slightly
above atmospheric pressure. The median volume re-
quired to reach an intra-articular pressure of 50 mmHg
was 70 ml (range 15 to 136 ml). Twelve of seventeen
participants judged themselves to be completely pain
free immediately after the joint infusion procedure; the
remainder rated their pain ≤5 out of 100.
Corticomotor excitability
There was no significant difference in quadriceps MEP
area between the two baseline measurements in either the
resting or the active conditions (both P >0.15). Following
joint infusion, quadriceps MEP area increased significantly
compared to B1 during the resting (P = 0.01) and activeBaseline 1 Baseline 2 Post-infusion
MEP area
Resting 1.00 ± 0.00 1.05 ± 0.08 1.42 ± 0.13*
Active 1.00 ± 0.00 1.10 ± 0.07 1.30 ± 0.11*
SICI
Resting 0.38 ± 0.04 0.39 ± 0.04 0.39 ± 0.04
Active 0.75 ± 0.06 0.69 ± 0.04 0.76 ± 0.05
ICF
Resting 3.10 ± 0.37 3.35 ± 0.53 3.49 ± 0.56
Active 1.61 ± 0.19 1.62 ± 0.22 1.71 ± 0.24
CSP duration (ms) 135 ± 6.06 134 ± 5.97 126 ± 5.93*
Data are presented as mean ± standard error of the mean. *Significant
difference from baseline 1 (P <0.05). MEP, motor evoked potential area
(normalised to baseline 1); SICI, short interval intracortical inhibition
(conditioned/unconditioned MEP); ICF, intracortical facilitation (conditioned/
unconditioned MEP); CSP, cortical silent period.
Figure 4 Quadriceps cortical silent period (CSP) duration before
and after experimental knee joint infusion. *Significant difference
from baseline 1 (P <0.05). Data are mean and one standard error of
the mean.
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the background EMG during the active condition did not
differ across time (P = 0.84).
Intracortical inhibition and facilitation
There was an overall effect of time on CSP duration
(F = 3.56; P = 0.04). CSP duration did not differ between
the two baseline measurements (P = 0.81). There was a
significant decrease in CSP duration following joint swell-
ing (P1) (P = 0.02) (Figure 4). There was no significant
difference in the magnitude of SICI over time during ei-
ther the resting or active conditions (both P >0.39). There
was no significant change in ICF over time for either the
resting condition or the active condition (both P >0.80).
The area of the test MEP used to calculate SICI and ICF
did not differ across measurement intervals during either
the resting or active conditions (both P >0.54).
Discussion
Knee joint swelling has consistently been shown to pre-
vent full neural activation of the quadriceps muscle
[16-18,20,21,34], which is at least partly due to a strong
spinal reflex inhibition of the quadriceps α-motoneuron
pool [20,25]. Despite these consistent findings across
many different studies, we observed a significant increase
in quadriceps MEP area after experimental joint infusion,
suggesting an increase, rather than a decrease, in quadri-
ceps corticomotor excitability. This observation was made
with the muscle at rest and during a voluntary contraction.
While somewhat paradoxical, our findings are supported
by similar observations in patients with chronic anterior
knee pain [27] and anterior cruciate ligament (ACL) injury
[26], where quadriceps corticomotor excitability was in-
creased compared to healthy control participants, or the
uninjured limb. As corticomotor excitability is partlyFigure 3 Quadriceps motor evoked potential (MEP) area
(normalised to Baseline 1 MEP area) measured at rest and
during voluntary contraction (approximately 10% maximum
effort voluntary contraction (MVC)) before and after
experimental knee joint infusion. *Significant difference from
baseline 1 (P <0.05). Data are mean and one standard error of
the mean.determined by α-motoneuron excitability, our observa-
tions suggest that, despite inhibiting the quadriceps α-
motoneuron pool, knee joint swelling leads to an increase
in excitability elsewhere in the corticomotor pathway.
While speculative, such a change may reflect a compensa-
tory mechanism by the central nervous system in an at-
tempt to maintain neural drive to the muscle.
The current study is the first to use paired pulse TMS
to determine the role of intracortical interneurons in the
response to articular swelling. We found no evidence
that either SICI or ICF are altered by experimental knee
joint swelling, suggesting that the excitability of the in-
terneurons underlying these responses was not altered.
In contrast, we observed a significant reduction in CSP
duration after joint infusion. While the initial 50 to
100 ms of the CSP relates to spinal inhibitory processes,
the second component of the CSP (and thus its dur-
ation) reflects the suppression of corticospinal output by
cortical inhibitory interneurons [35,36]. Furthermore,
pharmacological studies have shown that CSP duration
is lengthened by gamma-Aminobutyric acid (GABA) re-
uptake inhibitors [37] and GABA agonists [38]. Thus,
the reduction in CSP duration likely reflects reduced
GABAergic inhibition at the level of the motor cortex
following joint effusion [39]. Such a change may at least
partly explain the observed increase in quadriceps corti-
comotor excitability.
Interestingly, the observed reduction in CSP duration is at
odds with findings in patients who had suffered a unilateral
ACL injury, where no side-to-side differences in CSP dur-
ation were found despite an increase in quadriceps cortico-
motor excitability on the injured compared to the uninjured
side [26]. This could reflect differences in the mechanism(s)
underlying increased corticomotor excitability with acute
(experimental) and chronic joint injury. Importantly, other
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of joint afferent input [40] may also influence the excitability
of corticomotor and intracortical pathways.
In this regard, it should be noted that while experi-
mental joint infusion provides a model of joint injury
that has consistently been shown to induce potent quad-
riceps AMI, it does not accurately mimic the afferent
discharge from a joint affected by trauma or pathology.
Experimental joint infusion greatly increases the dis-
charge of group-II joint afferents [23] but in the absence
of inflammation, is unlikely to activate a large portion of
group-III and -IV afferents. This is demonstrated by the
fact that experimental swelling rarely evokes pain, as ob-
served in the current and previous studies [16,34,41].
Thus, it remains to be seen whether an increase in noci-
ceptive output from group-III and -IV knee joint affer-
ents influences corticomotor excitability and/or alters
the excitability of intracortical pathways. This should be
explored in future research, particularly given recent
findings that experimental knee pain impairs quadriceps
muscle activation [42] and experimental muscle pain
increases intracortical inhibition in hand muscles [43].
Conclusion
In conclusion, we observed an increase in quadriceps corti-
comotor excitability following experimental knee joint infu-
sion. This may be at least partly explained by a reduction in
cortical GABAergic inhibition, as CSP duration was also
reduced. Our findings provide no evidence for a cortical
contribution to quadriceps AMI and suggest that ongoing
spinal reflex inhibition may be sufficient to explain the
marked neural activation deficit that occurs following acute
knee injury, knee surgery and in chronic knee joint patholo-
gies. However, further research is needed to confirm these
findings in different patient populations and in response to
other relevant factors such as joint pain.
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